Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

What's the Outlook for Novavax Stock?

TheMotleyFool

0 0

Novavax (NASDAQ: NVAX) has been a big winner for investors since the beginning of the pandemic. However, concerns about delays in regulatory filings for the company's COVID-19 vaccine candidate have caused the stock to slide. In this Motley Fool Live video recorded on Oct. 13, Motley Fool contributors Keith Speights and Brian Orelli answer a viewer's question about the outlook for Novavax.

Source Fool.com

Like: 0

NVAX

Share